Literature DB >> 32393901

Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice.

Elliot D Mock1, Mohammed Mustafa2, Ozge Gunduz-Cinar3, Resat Cinar4, Gavin N Petrie5, Vasudev Kantae1,6, Xinyu Di6, Daisuke Ogasawara7, Zoltan V Varga8, Janos Paloczi8, Cristina Miliano9, Giulia Donvito2, Annelot C M van Esbroeck1, Anouk M F van der Gracht1, Ioli Kotsogianni1, Joshua K Park4, Andrea Martella1, Tom van der Wel1,10, Marjolein Soethoudt1, Ming Jiang1,10, Tiemen J Wendel1, Antonius P A Janssen1,10, Alexander T Bakker1, Colleen M Donovan3, Laura I Castillo3, Bogdan I Florea11, Jesse Wat12, Helma van den Hurk12, Matthias Wittwer13, Uwe Grether13, Andrew Holmes3, Constant A A van Boeckel1,12, Thomas Hankemeier6, Benjamin F Cravatt7, Matthew W Buczynski9, Matthew N Hill5, Pal Pacher8, Aron H Lichtman2,14, Mario van der Stelt15,16.   

Abstract

N-acylethanolamines (NAEs), which include the endocannabinoid anandamide, represent an important family of signaling lipids in the brain. The lack of chemical probes that modulate NAE biosynthesis in living systems hamper the understanding of the biological role of these lipids. Using a high-throughput screen, chemical proteomics and targeted lipidomics, we report here the discovery and characterization of LEI-401 as a CNS-active N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor. LEI-401 reduced NAE levels in neuroblastoma cells and in the brain of freely moving mice, but not in NAPE-PLD KO cells and mice, respectively. LEI-401 activated the hypothalamus-pituitary-adrenal axis and impaired fear extinction, thereby emulating the effect of a cannabinoid CB1 receptor antagonist, which could be reversed by a fatty acid amide hydrolase inhibitor. Our findings highlight the distinctive role of NAPE-PLD in NAE biosynthesis in the brain and suggest the presence of an endogenous NAE tone controlling emotional behavior.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32393901      PMCID: PMC7468568          DOI: 10.1038/s41589-020-0528-7

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  52 in total

Review 1.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 2.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

3.  Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids.

Authors:  Paola Magotti; Inga Bauer; Miki Igarashi; Masih Babagoli; Roberto Marotta; Daniele Piomelli; Gianpiero Garau
Journal:  Structure       Date:  2015-02-12       Impact factor: 5.006

Review 4.  Supply and demand for endocannabinoids.

Authors:  Bradley E Alger; Jimok Kim
Journal:  Trends Neurosci       Date:  2011-04-18       Impact factor: 13.837

Review 5.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

Review 6.  Principles of bioactive lipid signalling: lessons from sphingolipids.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

7.  Molecular characterization of a phospholipase D generating anandamide and its congeners.

Authors:  Yasuo Okamoto; Jun Morishita; Kazuhito Tsuboi; Takeharu Tonai; Natsuo Ueda
Journal:  J Biol Chem       Date:  2003-11-21       Impact factor: 5.157

Review 8.  Peripheral gating of pain signals by endogenous lipid mediators.

Authors:  Daniele Piomelli; Oscar Sasso
Journal:  Nat Neurosci       Date:  2014-01-28       Impact factor: 24.884

9.  Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family.

Authors:  Jun Wang; Yasuo Okamoto; Jun Morishita; Kazuhito Tsuboi; Akira Miyatake; Natsuo Ueda
Journal:  J Biol Chem       Date:  2006-03-09       Impact factor: 5.157

Review 10.  The endocannabinoid system in guarding against fear, anxiety and stress.

Authors:  Beat Lutz; Giovanni Marsicano; Rafael Maldonado; Cecilia J Hillard
Journal:  Nat Rev Neurosci       Date:  2015-12       Impact factor: 34.870

View more
  20 in total

1.  Structure-Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N-Acylphosphatidylethanolamine Phospholipase D.

Authors:  Elliot D Mock; Ioli Kotsogianni; Wouter P F Driever; Carmen S Fonseca; Jelle M Vooijs; Hans den Dulk; Constant A A van Boeckel; Mario van der Stelt
Journal:  J Med Chem       Date:  2020-12-31       Impact factor: 7.446

Review 2.  Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.

Authors:  Andrew Scheyer; Farhana Yasmin; Saptarnab Naskar; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

3.  Endocannabinoid Metabolism and Transport as Drug Targets.

Authors:  Francesca Ciaramellano; Federico Fanti; Lucia Scipioni; Mauro Maccarrone; Sergio Oddi
Journal:  Methods Mol Biol       Date:  2023

Review 4.  Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development.

Authors:  Lu Hou; Jian Rong; Ahmed Haider; Daisuke Ogasawara; Cassis Varlow; Michael A Schafroth; Linjing Mu; Jiefeng Gan; Hao Xu; Christopher J Fowler; Ming-Rong Zhang; Neil Vasdev; Simon Ametamey; Benjamin F Cravatt; Lu Wang; Steven H Liang
Journal:  J Med Chem       Date:  2020-12-30       Impact factor: 7.446

5.  Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer.

Authors:  Jian-Ang Li; Yefei Rong; Weilin Mao; Lei Zhang; Tiantao Kuang; Wenhui Lou
Journal:  Cell Cycle       Date:  2021-12-07       Impact factor: 4.534

6.  Neurobiology of cannabinoid receptor signaling
.

Authors:  Beat Lutz
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

Review 7.  Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies.

Authors:  Alexandre A Guerin; Eric J Nestler; Michael Berk; Andrew J Lawrence; Susan L Rossell; Jee Hyun Kim
Journal:  Neurosci Biobehav Rev       Date:  2020-11-17       Impact factor: 8.989

8.  In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity.

Authors:  Jordan S Farrell; Roberto Colangeli; Ao Dong; Antis G George; Kwaku Addo-Osafo; Philip J Kingsley; Maria Morena; Marshal D Wolff; Barna Dudok; Kaikai He; Toni A Patrick; Keith A Sharkey; Sachin Patel; Lawrence J Marnett; Matthew N Hill; Yulong Li; G Campbell Teskey; Ivan Soltesz
Journal:  Neuron       Date:  2021-08-04       Impact factor: 18.688

Review 9.  Updating Phospholipase A2 Biology.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshitaka Taketomi
Journal:  Biomolecules       Date:  2020-10-19

10.  Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.

Authors:  Shahar Azar; Shiran Udi; Adi Drori; Rivka Hadar; Alina Nemirovski; Kiran V Vemuri; Maya Miller; Dana Sherill-Rofe; Yhara Arad; Devorah Gur-Wahnon; Xiaoling Li; Alexandros Makriyannis; Danny Ben-Zvi; Yuval Tabach; Iddo Z Ben-Dov; Joseph Tam
Journal:  Mol Metab       Date:  2020-09-26       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.